Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick H Kim

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Cardiology and Therapy|March 7, 2024
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS DatasetRichard Channick, Kelly M Chin, Vallerie V McLaughlin, et al.
Pulmonary Circulation|November 3, 2022
Patient selection for balloon pulmonary angioplasty: Six-year results from a high volume PTE surgical centerDavid S Poch, Ehtisham Mahmud, Mitul Patel, et al.
The Lancet. Respiratory Medicine|June 11, 2019
Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trialOlivier Sitbon, Jaume Bosch, Emmanuelle Cottreel, et al.
Advances in Therapy|November 19, 2025
Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS StudiesLana D Melendres-Groves, Richard N Channick, Kelly M Chin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 2, 2021
Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERENick H Kim, Anna R Hemnes, Murali M Chakinala, et al.
American Journal of Obstetrics & Gynecology MFM|March 31, 2021
Pregnancy and pulmonary arterial hypertension: a case series and literature reviewJenny Z Yang, Timothy M Fernandes, Nick H Kim, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 2, 2023
The spatial-temporal dynamics of pulmonary blood flow are altered in pulmonary arterial hypertensionAbhilash S Kizhakke Puliyakote, G Kim Prisk, Ann R Elliott, et al.
Echocardiography (Mount Kisco, N.Y.)|July 5, 2013
Echocardiographic estimation of pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension: utility of right heart Doppler measurementsYu Xie, Benita M Burke, Alex Kopelnik, et al.
The European Respiratory Journal|September 26, 2024
Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)Nick H Kim, Richard Channick, Marion Delcroix, et al.
The European Respiratory Journal|December 15, 2018
Chronic thromboembolic pulmonary hypertensionNick H Kim, Marion Delcroix, Xavier Jais, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Cardiology and Therapy|March 7, 2024
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS DatasetRichard Channick, Kelly M Chin, Vallerie V McLaughlin, et al.
Pulmonary Circulation|November 3, 2022
Patient selection for balloon pulmonary angioplasty: Six-year results from a high volume PTE surgical centerDavid S Poch, Ehtisham Mahmud, Mitul Patel, et al.
The Lancet. Respiratory Medicine|June 11, 2019
Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trialOlivier Sitbon, Jaume Bosch, Emmanuelle Cottreel, et al.
Advances in Therapy|November 19, 2025
Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS StudiesLana D Melendres-Groves, Richard N Channick, Kelly M Chin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 2, 2021
Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERENick H Kim, Anna R Hemnes, Murali M Chakinala, et al.
American Journal of Obstetrics & Gynecology MFM|March 31, 2021
Pregnancy and pulmonary arterial hypertension: a case series and literature reviewJenny Z Yang, Timothy M Fernandes, Nick H Kim, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 2, 2023
The spatial-temporal dynamics of pulmonary blood flow are altered in pulmonary arterial hypertensionAbhilash S Kizhakke Puliyakote, G Kim Prisk, Ann R Elliott, et al.
Echocardiography (Mount Kisco, N.Y.)|July 5, 2013
Echocardiographic estimation of pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension: utility of right heart Doppler measurementsYu Xie, Benita M Burke, Alex Kopelnik, et al.
The European Respiratory Journal|September 26, 2024
Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)Nick H Kim, Richard Channick, Marion Delcroix, et al.
The European Respiratory Journal|December 15, 2018
Chronic thromboembolic pulmonary hypertensionNick H Kim, Marion Delcroix, Xavier Jais, et al.
Pageof 12